Correlation Between Intellia Therapeutics and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Intellia Therapeutics and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Vertex Pharmaceuticals.
Diversification Opportunities for Intellia Therapeutics and Vertex Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Intellia and Vertex is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Vertex Pharmaceuticals
Given the investment horizon of 90 days Intellia Therapeutics is expected to generate 1.77 times more return on investment than Vertex Pharmaceuticals. However, Intellia Therapeutics is 1.77 times more volatile than Vertex Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 1,433 in Intellia Therapeutics on August 31, 2024 and sell it today you would earn a total of 88.00 from holding Intellia Therapeutics or generate 6.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Intellia Therapeutics |
| Vertex Pharmaceuticals |
Intellia Therapeutics and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Vertex Pharmaceuticals
The main advantage of trading using opposite Intellia Therapeutics and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |